Authors | Sample size | Total | Gender (female) | Mean age (years) | Intervention | Country | Study type | Follow-up (postoperative) | Outcome assessment | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T | C | TÂ (%) | CÂ (%) | T | C | T | C | ||||||
Zhang et al. 2016 [15] | 32 | 31 | 63 | 50 | 48 | 56.15 ± 2.15 | 55.35 ± 3.01 | PEEK | Ti | China | Prospective | 4th, 12th, 24th weeks | ODI Bone graft fusion rate |
Sun et al. 2016 [16] | 24 | 24 | 48 | 46 | 50 | 61.5 ± 5.3 | 61.3 ± 2.1 | PEEK | Ti | China | Prospective | 4th, 12th, 24th, 48th months | VAS JOA Bone graft fusion rate |
Wang et al. 2020 [17] | 27 | 27 | 54 | 67 |  | 54.6 ± 4.3 |  | PEEK | Ti | China | Prospective | 12th, 24th, 48th weeks | ODI JOA Bone graft fusion rate Adverse event |
Li et al. 2019 [18] | 21 | 26 | 47 | 45 |  | 54.6 ± 4.3 |  | PEEK | Ti | China | Prospective | 4th, 12th, 72th,144th weeks | Operation time Intraoperative blood loss Postoperative drainage Length of stay ODI VAS |
Tang et al. 2020 [19] | 58 | 48 | 106 | 55 | 58 | 57.45 ± 7.37 | 56.39 ± 7.26 | PEEK | Ti | China | Prospective | 2th, 12th, 48th weeks | Operation time Intraoperative blood loss Postoperative drainage Length of stay ODI VAS Intervertebral ROM Adverse event |
Ding et al. 2020 [20] | 35 | 35 | 70 | 57 | 40 | 56.16 ± 2.16 | 55.36 ± 3.02 | PEEK | Ti | China | Prospective | 4th, 12th, 24th weeks | ODI JOA Intervertebral ROM Bone graft fusion rate Adverse event |
Qi et al. 2013 [21] | 20 | 21 | 41 | 45 | 48 | 48.9(38–63) | 50.4(32–74) | PEEK | Ti | China | Prospective | 12th, 24th, 48th weeks | VAS for LBP VAS for LP JOA JOA recovery rate DH |
Huang et al. 2016 [22] | 21 | 20 | 41 | 33 | 40 | 65.2 ± 4.1 | 64.7 ± 5.4 | PEEK | Ti | China | Prospective | 3th, 6th, 12th months | ODI JOA Bone graft fusion rate |
Li et al. 2015 [23] | 25 | 25 | 50 | 46 |  | 44.54 ± 1.35 |  | PEEK | Ti | China | Retrospective | 1th, 6th, 12th months | JOA ODI Bone graft fusion rate DH Intervertebral ROM |
Han et al. 2016 [24] | 16 | 16 | 32 | 53 |  | 61.2 ± 1.3 |  | PEEK | Ti | China | Retrospective | 1th, 3th, 6th, 12th months | VAS for LBP VAS for LP JOA |
Lu et al. 2017 [25] | 24 | 24 | 48 | 46 |  | 60.2 ± 1.2 |  | PEEK | Ti | China | Retrospective | 3th, 6th, 12th months | VAS for LBP VAS for LP JOA |
Pang et al. 2020 [26] | 30 | 30 | 60 | 67 | 60 | 56 ± 13 | 53 ± 13 | PEEK | Ti | China | Retrospective | 3th, 6th, 12th, 24th, 36th months | JOA bone graft fusion rate JOA recovery rate |
Yang et al. 2015 [27] | 24 | 27 | 51 | 46 | 56 | 47.5 ± 5.3 | 49.9 ± 5.3 | PEEK | Ti | China | Retrospective | 3th, 6th, 12th, 24th months | VAS for LBP VAS for LP ODI Bone graft fusion rate DH |
Yu et al. 2012 [28] | 13 | 15 | 28 | 31 | 60 | 53.2 ± 11.3 | 55.3 ± 10.3 | PEEK | Ti | China | Retrospective | 3th, 6th months | JOA Bone graft fusion rate JOA recovery rate |
Xu et al. 2012 [29] | 20 | 20 | 40 | 45 | 60 | 50.35 ± 9.16 | 56.74 ± 13.86 | PEEK | Ti | China | Retrospective | 7–16 months | ODI Bone graft fusion rate |